FPHAX vs. FCVSX

Last updated Aug 4, 2026

FPHAX (Fidelity Select Pharmaceuticals Portfolio) and FCVSX (Fidelity Convertible Securities Fund) are both mutual funds - FPHAX is a Health & Biotech Equities fund managed by Fidelity, while FCVSX is a Convertible Bonds fund managed by Fidelity. Over the past 10 years, FPHAX returned 11.46%/yr vs 11.61%/yr for FCVSX. Their 0.61 correlation means they have sometimes moved together and sometimes differently. Both charge a 0.67% expense ratio.

Performance

FPHAX vs. FCVSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Convertible Securities Fund (FCVSX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FPHAX achieves a 11.86% return, which is significantly lower than FCVSX's 14.46% return. Both investments have delivered pretty close results over the past 10 years, with FPHAX having a 11.46% annualized return and FCVSX not far ahead at 11.61%.

FPHAX

• 1D: -0.82%
• 1M: -5.31%
• 6M: 8.15%
• YTD: 11.86%
• 1Y: 47.75%
• 3Y*: 19.16%
• 5Y*: 12.79%
• 10Y*: 11.46%
• ALL TIME*: 9.60%

FCVSX

• 1D: -0.02%
• 1M: -3.29%
• 6M: 8.54%
• YTD: 14.46%
• 1Y: 15.36%
• 3Y*: 12.82%
• 5Y*: 6.49%
• 10Y*: 11.61%
• ALL TIME*: 9.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
FCVSX Fidelity Convertible Securities Fund	$0.00	$0.00	$0.00
FPHAX Fidelity Select Pharmaceuticals Portfolio	$0.00	$0.00	$0.00

FPHAX vs. FCVSX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FPHAX Fidelity Select Pharmaceuticals Portfolio	11.86%	30.41%	9.39%	12.54%	0.94%	11.79%	11.16%	31.73%	5.41%	10.70%
FCVSX Fidelity Convertible Securities Fund	14.46%	8.52%	13.91%	11.42%	-15.33%	9.95%	42.52%	28.58%	-1.29%	9.03%

Correlation

The correlation between FPHAX and FCVSX is 0.24, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.24
Correlation (3Y) Balances recent behavior with more history.	0.38
Correlation (5Y) Shows whether the relationship held over a longer period.	0.45
Correlation (10Y) Provides a long-term view across more market conditions.	0.52
Correlation (All Time) Calculated using the full available price history since Jun 18, 2001	0.61

Over the past year, the correlation between FPHAX and FCVSX has dropped to 0.24 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.

Return for Risk

FPHAX vs. FCVSX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FPHAX

FPHAX Risk / Return Rank: 92
FPHAX Sharpe Ratio Rank: 94
FPHAX Sortino Ratio Rank: 92
FPHAX Omega Ratio Rank: 83
FPHAX Calmar Ratio Rank: 96
FPHAX Martin Ratio Rank: 93

FCVSX

FCVSX Risk / Return Rank: 19
FCVSX Sharpe Ratio Rank: 17
FCVSX Sortino Ratio Rank: 15
FCVSX Omega Ratio Rank: 19
FCVSX Calmar Ratio Rank: 24
FCVSX Martin Ratio Rank: 22

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FPHAX vs. FCVSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Convertible Securities Fund (FCVSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FPHAX	FCVSX	Difference
Sharpe ratio: Return per unit of total volatility	2.48	0.71	+1.77
Sortino ratio: Return per unit of downside risk	3.54	1.00	+2.55
Omega ratio: Gain probability vs. loss probability	1.41	1.14	+0.26
Calmar ratio: Return relative to maximum drawdown	4.81	1.21	+3.60
Martin ratio: Return relative to average drawdown	14.53	3.31	+11.23

FPHAX vs. FCVSX - Sharpe Ratio Comparison

The current FPHAX Sharpe Ratio is 2.48, which is higher than the FCVSX Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of FPHAX and FCVSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FPHAX vs. FCVSX - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum FCVSX drawdown of -58.76%. Use the drawdown chart below to compare losses from any high point for FPHAX and FCVSX.

Drawdown Indicators

	FPHAX	FCVSX	Difference
Max Drawdown Largest peak-to-trough decline	-38.26%	-58.76%	+20.50%
Max Drawdown (1Y) Largest decline over 1 year	-10.33%	-11.39%	+1.06%
Max Drawdown (3Y) Largest decline over 3 years	-28.82%	-14.56%	-14.26%
Max Drawdown (5Y) Largest decline over 5 years	-28.82%	-24.18%	-4.64%
Max Drawdown (10Y) Largest decline over 10 years	-28.82%	-25.08%	-3.74%
Current Drawdown Current decline from peak	-6.02%	-8.72%	+2.70%
Average Drawdown Average peak-to-trough decline	-9.13%	-7.21%	-1.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.41%	4.16%	-0.75%

Volatility

FPHAX vs. FCVSX - Volatility Comparison

Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 6.44% compared to Fidelity Convertible Securities Fund (FCVSX) at 5.98%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than FCVSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FPHAX	FCVSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.44%	5.98%	+0.46%
Volatility (6M) Calculated over the trailing 6-month period	15.28%	13.94%	+1.34%
Volatility (1Y) Calculated over the trailing 1-year period	20.25%	19.35%	+0.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.35%	14.33%	+4.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.93%	14.07%	+3.86%

FPHAX vs. FCVSX - Expense Ratio Comparison

Both FPHAX and FCVSX have an expense ratio of 0.67%.

Dividends

FPHAX vs. FCVSX - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 4.97%, more than FCVSX's 1.43% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FCVSX Fidelity Convertible Securities Fund	1.43%	2.21%	7.47%	2.13%	3.78%	20.64%	10.75%	3.28%	9.86%	4.11%	4.90%	10.41%
FPHAX Fidelity Select Pharmaceuticals Portfolio	4.97%	5.68%	1.90%	8.08%	5.18%	11.09%	8.85%	8.33%	1.65%	1.62%	1.07%	12.63%

Frequently Asked Questions

Can I hold both FPHAX and FCVSX in my portfolio?

FPHAX and FCVSX have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FPHAX or FCVSX?

FPHAX has higher volatility (6.44%) compared to FCVSX (5.98%). In terms of maximum drawdown, FPHAX dropped -38.26% vs FCVSX's -58.76%.

Which has better risk-adjusted returns?

FPHAX currently has the higher Sharpe Ratio (2.48 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.